3,495 Shares in Agilent Technologies, Inc. (NYSE:A) Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,495 shares of the medical research company's stock, valued at approximately $470,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. CKW Financial Group lifted its holdings in Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. lifted its stake in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares during the period. Lee Danner & Bass Inc. bought a new stake in Agilent Technologies in the fourth quarter valued at $29,000. Hanson & Doremus Investment Management increased its position in Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock valued at $35,000 after purchasing an additional 105 shares during the period. Finally, OFI Invest Asset Management bought a new position in Agilent Technologies in the 4th quarter worth $37,000.

Insider Activity

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The disclosure for this sale can be found here.

Remove Ads

Agilent Technologies Stock Down 2.0 %

Shares of NYSE A traded down $2.42 during midday trading on Friday, hitting $116.55. The stock had a trading volume of 1,772,856 shares, compared to its average volume of 1,768,077. The business's 50 day moving average is $134.29 and its 200-day moving average is $136.64. Agilent Technologies, Inc. has a 52 week low of $116.36 and a 52 week high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a market cap of $33.23 billion, a P/E ratio of 26.79, a PEG ratio of 3.34 and a beta of 1.11.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. As a group, analysts predict that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.85%. Agilent Technologies's dividend payout ratio is presently 22.76%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on A shares. Bank of America reduced their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research report on Friday, December 13th. StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Wells Fargo & Company lowered their target price on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research note on Monday, December 9th. Robert W. Baird reduced their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research note on Thursday, February 27th. Finally, Barclays raised Agilent Technologies from an "underweight" rating to an "equal weight" rating and raised their price objective for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $150.83.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.